Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Wärtsilä Testing Update

3 Mar 2023 07:00

RNS Number : 7432R
Quadrise Fuels International PLC
03 March 2023
 

3 March 2023

Quadrise Fuels International Plc ("Quadrise" or the "Company")

Wärtsilä Testing Update

Quadrise Fuels International Plc (AIM:QFI), the supplier of innovative energy solutions for a cleaner planet, provides the following update further to the Company's announcement of 16 January 2023, on the testing of its bioMSAR™ fuel carried out by Wärtsilä Services Switzerland ("Wärtsilä") in December 2022.

As part of Quadrise's ongoing Framework Agreement with MSC Shipmanagement, optical combustion and engine wear tests of bioMSAR™ were carried out as a necessary precursor to commercial-scale vessel trials.

The optical combustion test, against MSAR® and diesel fuels, has confirmed bioMSAR™ to have similar injection and combustion properties as MSAR® and that bioMSAR™ is therefore expected to behave similarly to MSAR® when utilised in medium and slow-speed diesel engines.

Extended wear tests over a 250 hour period were also completed successfully. 

The Company is pleased to confirm that, as a result of these test results, bioMSAR™ can proceed to the next phase of assessment, with hazard identification and operability studies now scheduled ahead of commercial vessel testing on the MSC Leandra and further announcements will be made, as appropriate, in due course.

Jason Miles, Chief Executive of Quadrise, commented:

 

"The extensive tests undertaken by Wärtsilä clearly demonstrate the suitability of bioMSAR™ for use in both marine and power plant applications. This is an important step in clearing the fuel for commercial supply and we look forward to progressing our final round of tests ahead of planned vessel trials with MSC for both MSAR® and bioMSAR™ later this year."

 

For additional information, please contact:

 

Quadrise Fuels International Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Broker

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more: www.quadrisefuels.com

 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSSIEFEEDSESD
Date   Source Headline
4th Dec 200712:16 pmRNSGrant of Options
3rd Dec 20074:40 pmRNSDirectorate Change
8th Oct 20077:01 amRNSFinal Results
17th Aug 20072:47 pmRNSAIM Notice (Rule 26)
17th Jul 20077:01 amRNSUpdate on Plans
6th Jul 20074:31 pmRNSDirector/PDMR Shareholding
19th Jun 200711:44 amRNSEquity Stake
26th Apr 200711:36 amRNSAnnual General Meeting
21st Mar 200712:00 pmRNSInterim Results
7th Mar 20072:33 pmRNSNotice of Results
26th Jan 20077:01 amRNSUpdate on Activities
9th Jan 20072:14 pmRNSDirector/PDMR Shareholding
18th Dec 200611:15 amRNSTotal Voting Rights
24th Nov 20062:37 pmRNSIssue of Equity
15th Nov 20064:34 pmRNSDirector/PDMR Shareholding
14th Nov 20064:33 pmRNSDirector/PDMR Shareholding
13th Nov 200611:21 amRNSDirector/PDMR Shareholding
10th Nov 200610:38 amRNSDirector/PDMR Shareholding
6th Nov 20064:18 pmRNSIssue of Equity
2nd Nov 200611:36 amRNSDirector/PDMR Shareholding
5th Oct 200610:27 amRNSStatement re Orimulsion
21st Sep 20064:29 pmRNSUpdate on Activities
17th Jul 20064:16 pmRNSChange in year end
19th Jun 200610:32 amRNSDirector/PDMR Shareholding
31st May 20067:02 amRNSFinal Results
19th Apr 200611:56 amRNSAdmission to AIM
18th Apr 20063:25 pmRNSEGM Statement
24th Mar 20069:58 amRNSSch 1 - Quadrise Fuels Intl
23rd Mar 20067:01 amRNSInterim Results
23rd Mar 20067:01 amRNSRestoration - Zareba PLC
23rd Mar 20067:00 amRNSAcquisition
17th Mar 200612:39 pmRNSLetter to Shareholders
3rd Jan 20063:58 pmRNSDirectorate Change
12th Dec 20055:18 pmRNSStatement re. Suspension
12th Dec 20055:17 pmRNSRelated Party Transaction
12th Dec 20052:15 pmRNSSuspension - Zareba PLC
9th Dec 20057:01 amRNSChange of Adviser
18th Oct 200511:03 amRNSDirector/PDMR Shareholding
30th Sep 20054:22 pmRNSInterim Results
8th Jun 20057:00 amRNSAcquisition
14th Mar 200511:46 amRNSIssue of Equity
25th Feb 20052:35 pmRNSHolding(s) in Company
21st Feb 20055:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.